Suzhou Redgiabiotech to Attend CMCchina2026

We will leverage the platform to engage with global and domestic biopharma professionals, including manufacturers, research institutes and supply chain service providers. Prioritizing pragmatic industry dialogue over conventional product promotion, Redgiabiotech will focus on technical communication, supply chain alignment and standardized industrial cooperation discussions throughout the event.Up to 50,000 peers, experts and customers are projected to join the event.

On-site team discussions will center on industry development trends, standardized production management, consistent biopharmaceutical material supply and cross-regional collaboration models. All on‑site communications shall be conducted on an objective, factual basis. Integrity is the cornerstone of business and the impetus for sustained growth.Through our participation in CMCchina2026, we look forward to discussing industry trends with peers and clients, identifying more cooperation opportunities and forging tighter partnerships.

We specialize in biopharmaceutical material supply, quality control support and industrial chain collaboration services for the biopharma industry. Guided by standardized operations, we maintain an open and pragmatic approach toward industry collaboration and communication. We hope to connect with you to talk through shared cooperation prospects.